Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments ...

SAN FRANCISCO and SUZHOU,China, April 25, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company t ...

The Melanoma Research Foundation (MRF) is pleased to announce the official launch of its annual award-winning #GetNaked campaign in recognition of Melanoma Awareness Month this May.

Last Friday in courtroom 2B of the Loudoun County Circuit Court, when the judge called out the next case on the docket, “Blue ...

IBI3014 is a bispecific ADC targeting TROP2 and PD-L1. Its dual mechanism integrates TROP2-directed tumor killing with PD-L1 immune checkpoint blockade, enhancing immunogenic cell death and T cell ...

Assam University Silchar Unit has lodged a First Information Report (FIR) against Md. Bahauddin Choudhury, a student from the ...

NurExone's ExoTherapy platform enables precise, minimally-invasive delivery of therapies to injured tissues using exosomes as an advanced delivery system. With a growing body of preclinical data and ...

The “Beyond Burger” provides a plant-based option for those who want the burger experience without the meat. It’s served on a ...

The “Pulled Pork BBQ” combines tender braised pork with tangy BBQ sauce on a brioche roll, creating a handheld masterpiece ...

T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types of advanced thyroid cancer, according to ...

Mark Zuckerberg, who controls Facebook through Bay Area tech giant Meta, wants a return to "OG Facebook." The company is now ...